Related Experiment Video
Updated: Aug 11, 2026

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
[Portal anticoagulation in preventing thrombosis after porta-azygous devascularization for portal hypertension]
1Department of Surgery, Henan Provincial People's Hospital, Zhengzhou 450003, China.
Insights
Anticoagulation therapy effectively prevents thrombosis after porta-azygous devascularization for portal hypertension. This method significantly reduced thrombosis rates compared to standard care, improving patient outcomes.
Area of Science:
- Gastroenterology and Hepatology
- Vascular Surgery
- Hematology
Context:
- Portal hypertension is a serious complication of liver cirrhosis.
- Porta-azygous devascularization is a surgical procedure to manage portal hypertension.
- Thrombosis is a significant risk following this procedure.
Purpose:
- To evaluate the efficacy of portal anticoagulation therapy in preventing thrombosis after porta-azygous devascularization.
- To compare the incidence of thrombosis in patients receiving anticoagulation versus those who do not.
Summary:
- A study involving 71 patients with portal hypertension due to cirrhosis compared anticoagulation therapy (Group A, n=36) with standard care (Group B, n=35).
- Group A received anticoagulation via a splenic vein branch shunt post-operation.
- Color Doppler examination at 3 months showed no thrombosis in Group A, versus 37.14% in Group B.
Impact:
- Portal anticoagulation therapy is demonstrated as an effective strategy to prevent portal thrombosis.
- This approach can significantly reduce the incidence of post-operative thrombosis after porta-azygous devascularization.
- Improved prevention of thrombosis may lead to better long-term outcomes for patients with portal hypertension.
Objective:
To study the prevention method for thrombosis after porta-azygous devascularization for portal hypertension.
Methods:
71 patients with portal hypertension due to cirrhosis were divided into group A (36 patients) and group B (35 patients). In group A, a anticoagulation tube was inserted via splenic vein branch during shunt and anticoagulation therapy was given after operation.
Results:
All the patients received color Doppler examination 3 months after operation. No thrombosis occurred in the group A and thrombosis occurred in 13 patients (37.14%) in the group B.
Conclusion:
Portal anticoagulation therapy is the effective in preventing portal thrombosis after porta-azygous devascularization for portal hypertension.
Related Concept Videos
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Peripheral Artery Disease V: Postoperative Nursing Management
Hemodialysis I: Introduction
Portal Hypertension

